Skip to main content

Table 2 Univariate associations between lung function expressed as FEV1 and FVC in percent of predicted, adiponectin, smoking status, indices of adiposity, metabolic syndrome, obstructive sleep apnoea and C-reactive protein

From: The association between circulating adiponectin levels, lung function and adiposity in subjects from the general population; data from the Akershus Sleep Apnea Project

 

FEV1% predicted

FVC % predicted

Unstandardized beta (CI)

p

Unstandardized beta (CI)

p

ADPN (per SD)

1.012 (− 0.365, 2.388)

0.149

3.414 (2.047, 4.781)

< 0.001

Current smoking

−5.444 (−8.483, − 2.406)

< 0.001

−2.219 (−5.410, 0.972)

0.173

Previous smoking

0.645 (− 2.197, 3.487)

0.656

− 1.143 (−4.096, 1.811)

0.448

Weight (per 5 kg)

−0.661 (− 1.055, − 0.268)

0.001

− 1.119 (− 1.510, − 0.728)

< 0.001

BMI kg/m2

−0.466 (− 0.740, − 0.192)

0.001

−0.647 (− 0.922, − 0.371)

< 0.001

WHR

−38.297 (− 52.041, − 24.553)

< 0.001

−62.199 (−75.488, − 48.909)

< 0.001

Metabolic syndrome

−4.905 (−7.808, − 2.001)

0.001

− 7.375 -10.289, − 4.471)

< 0.001

OSA

−2.143 (− 4.911, 0.625)

0.129

− 3.923 (− 6.725, − 1.120)

0.006

CRP (per SD)

− 2.157 (− 3.524, − 0.791)

0.002

− 2.071 (− 3.457, − 0.685)

0.003

  1. FEV 1 forced expiratory volume during 1st second, FVC forced vital capacity, CI confidence interval, ADPN adiponectin, SD standard deviation, BMI body mass index, WHR waist-hip ratio, OSA obstructive sleep apnoea, CRP C-reactive protein